BACKGROUND: Understanding the ecology and evolution of influenza A viruses (IAV) in mammalian hosts is critical to reduce disease burden in production animals and lower zoonotic infection risk in humans. Recent advances in influenza surveillance in US swine populations allow for timely epidemiological, phylogenetic, and virological analyses that monitor emergence of novel viruses and assess changes in viral population dynamics. METHODS: To better understand IAV in the North American swine population, we undertook a phylogenetic analysis of 1075 HA, 1049 NA, and 1040 M sequences of IAV isolated from US swine during 2009-2012 through voluntary and anonymous submissions to the US Department of Agriculture IAV swine surveillance system. RESULTS: Analyses revealed changes in population dynamics among multiple clades of A/H1N1, A/H3N2, and A/H1N2 cocirculating in US swine populations during 2009-2012. Viral isolates were categorized into one of seven genetically and antigenically distinct hemagglutinin lineages: H1α, H1β, H1γ, H1δ1, H1δ2, H1pdm09, and H3 cluster IV. There was an increase in occurrence of H1δ1 in samples submitted, with a concurrent decrease in H1pdm09. H3 cluster IV exhibited increasing diversification, warranting a re-evaluation of phylogenetic nomenclature criteria. Although H3N2 represented 25% of identified viruses, this subtype was reported in increasing proportion of sequenced isolates since late 2011. CONCLUSIONS: Surveillance and reporting of IAV in US swine have increased since 2009, and we demonstrate a period of expanded viral diversity. These data may be used to inform intervention strategies of vaccine and diagnostic updates and changes in swine health management. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND: Understanding the ecology and evolution of influenza A viruses (IAV) in mammalian hosts is critical to reduce disease burden in production animals and lower zoonotic infection risk in humans. Recent advances in influenza surveillance in US swine populations allow for timely epidemiological, phylogenetic, and virological analyses that monitor emergence of novel viruses and assess changes in viral population dynamics. METHODS: To better understand IAV in the North American swine population, we undertook a phylogenetic analysis of 1075 HA, 1049 NA, and 1040 M sequences of IAV isolated from US swine during 2009-2012 through voluntary and anonymous submissions to the US Department of Agriculture IAV swine surveillance system. RESULTS: Analyses revealed changes in population dynamics among multiple clades of A/H1N1, A/H3N2, and A/H1N2 cocirculating in US swine populations during 2009-2012. Viral isolates were categorized into one of seven genetically and antigenically distinct hemagglutinin lineages: H1α, H1β, H1γ, H1δ1, H1δ2, H1pdm09, and H3 cluster IV. There was an increase in occurrence of H1δ1 in samples submitted, with a concurrent decrease in H1pdm09. H3 cluster IV exhibited increasing diversification, warranting a re-evaluation of phylogenetic nomenclature criteria. Although H3N2 represented 25% of identified viruses, this subtype was reported in increasing proportion of sequenced isolates since late 2011. CONCLUSIONS: Surveillance and reporting of IAV in US swine have increased since 2009, and we demonstrate a period of expanded viral diversity. These data may be used to inform intervention strategies of vaccine and diagnostic updates and changes in swine health management. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
Entities:
Keywords:
Epidemiology; influenza A virus; surveillance; swine; vaccines; zoonotic diseases
Authors: Pravina Kitikoon; Dachrit Nilubol; Barbara J Erickson; Bruce H Janke; Thayer C Hoover; Steve A Sornsen; Eileen L Thacker Journal: Vet Immunol Immunopathol Date: 2006-04-18 Impact factor: 2.046
Authors: Colin A Russell; Terry C Jones; Ian G Barr; Nancy J Cox; Rebecca J Garten; Vicky Gregory; Ian D Gust; Alan W Hampson; Alan J Hay; Aeron C Hurt; Jan C de Jong; Anne Kelso; Alexander I Klimov; Tsutomu Kageyama; Naomi Komadina; Alan S Lapedes; Yi P Lin; Ana Mosterin; Masatsugu Obuchi; Takato Odagiri; Albert D M E Osterhaus; Guus F Rimmelzwaan; Michael W Shaw; Eugene Skepner; Klaus Stohr; Masato Tashiro; Ron A M Fouchier; Derek J Smith Journal: Vaccine Date: 2008-09-12 Impact factor: 3.641
Authors: Pravina Kitikoon; Martha I Nelson; Mary Lea Killian; Tavis K Anderson; Leo Koster; Marie R Culhane; Amy L Vincent Journal: J Gen Virol Date: 2013-06 Impact factor: 3.891
Authors: Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier Journal: Science Date: 2004-06-24 Impact factor: 47.728
Authors: James Tamerius; Martha I Nelson; Steven Z Zhou; Cécile Viboud; Mark A Miller; Wladimir J Alonso Journal: Environ Health Perspect Date: 2010-11-19 Impact factor: 9.031
Authors: Alessio Lorusso; Amy L Vincent; Marie E Gramer; Kelly M Lager; Janice R Ciacci-Zanella Journal: Curr Top Microbiol Immunol Date: 2013 Impact factor: 4.291
Authors: Bryan S Kaplan; J Brian Kimble; Jennifer Chang; Tavis K Anderson; Phillip C Gauger; Alicia Janas-Martindale; Mary Lea Killian; Andrew S Bowman; Amy L Vincent Journal: J Virol Date: 2020-07-30 Impact factor: 5.103
Authors: Daniela S Rajão; Phillip C Gauger; Tavis K Anderson; Nicola S Lewis; Eugenio J Abente; Mary Lea Killian; Daniel R Perez; Troy C Sutton; Jianqiang Zhang; Amy L Vincent Journal: J Virol Date: 2015-08-26 Impact factor: 5.103
Authors: Brigitte E Martin; Hailiang Sun; Margaret Carrel; Fred L Cunningham; John A Baroch; Katie C Hanson-Dorr; Sean G Young; Brandon Schmit; Jacqueline M Nolting; Kyoung-Jin Yoon; Mark W Lutman; Kerri Pedersen; Kelly Lager; Andrew S Bowman; Richard D Slemons; David R Smith; Thomas DeLiberto; Xiu-Feng Wan Journal: Appl Environ Microbiol Date: 2017-09-15 Impact factor: 4.792
Authors: Daniela S Rajão; Rasna R Walia; Brian Campbell; Phillip C Gauger; Alicia Janas-Martindale; Mary Lea Killian; Amy L Vincent Journal: J Virol Date: 2017-01-31 Impact factor: 5.103
Authors: Brigitte E Martin; Andrew S Bowman; Lei Li; Jacqueline M Nolting; David R Smith; Larry A Hanson; Xiu-Feng Wan Journal: J Clin Microbiol Date: 2017-01-11 Impact factor: 5.948
Authors: Shibo Gao; Tavis K Anderson; Rasna R Walia; Karin S Dorman; Alicia Janas-Martindale; Amy L Vincent Journal: J Gen Virol Date: 2017-07-31 Impact factor: 3.891
Authors: Eugenio J Abente; Phillip C Gauger; Rasna R Walia; Daniela S Rajao; Jianqiang Zhang; Karen M Harmon; Mary Lea Killian; Amy L Vincent Journal: Virology Date: 2017-08-23 Impact factor: 3.616
Authors: Nicola S Lewis; Tavis K Anderson; Pravina Kitikoon; Eugene Skepner; David F Burke; Amy L Vincent Journal: J Virol Date: 2014-02-12 Impact factor: 5.103
Authors: Martha I Nelson; David E Wentworth; Marie R Culhane; Amy L Vincent; Cecile Viboud; Matthew P LaPointe; Xudong Lin; Edward C Holmes; Susan E Detmer Journal: J Virol Date: 2014-06-25 Impact factor: 5.103